Psilocybin Assisted Therapy
We support you in the application process to access Psilocybin Assisted Therapy for treatment-resistant mental health concerns.
Psilocybin Assisted Therapy
We support you in the application process to access Psilocybin Assisted Therapy for treatment-resistant mental health concerns.
Psilocybin Assisted Therapy is an option that can be explored when other modalities such as antidepressants or talk-therapy don’t work, and has been used as an adjunct to therapy since the 1970’s. While the safety and effectiveness of Psilocybin in therapy is still under investigation, Health Canada allows physicians to request access for unique cases of treatment-resistant mental health concerns, specifically depression and end-of-life.
Psilocybin & its potential benefits
Psilocybin is a naturally occurring psychedelic compound found in certain mushrooms, often known as “magic” or “psychedelic” mushrooms. These mushrooms have been used in spiritual and ritual practices by indigenous cultures for centuries. After ingestion, the body metabolizes psilocybin, transforming it into psilocin.
This converted compound, psilocin, interacts with the brain’s receptors, causing the altered states of consciousness associated with psilocybin ingestion. Through its unique properties, psilocybin can open the door to deep introspection, heightened sensory perception, and a profound sense of interconnectedness. In therapeutic settings, psilocybin helps to facilitate experiences that promote self-reflection, emotional exploration, and personal growth. Research suggests that psilocybin-assisted therapy may have long-lasting positive effects on mood, well-being, and can cause a renewed sense of meaning and purpose in life
- Can reduce depression: Can significantly lower depression symptoms, effective even in treatment-resistant cases
- Alleviates anxiety: Helps decrease anxiety, especially in individuals with life-threatening conditions
- Increases emotional openness: Boosts empathy and emotional openness, aiding in emotional processing and relationship improvements
- Decreases substance dependence: Shows promise in reducing addiction to substances like alcohol and nicotine
- Improves quality of life: Participants report enhanced overall well-being and life satisfaction
- Long-lasting effects: Benefits such as mood improvement can persist for months or years after the sessions
Ready to get started?
As you book an information call, we invite you to review these important considerations. They play a role in determining your eligibility for treatment. Your attention to these questions will help us better understand your needs and supports for your journey.
Applying to access Psilocybin Assisted Therapy
Clients can apply to access this unique mental health treatment through a specific application process, even though this treatment has not yet received official approval. This application process provides a unique opportunity for individuals dealing with challenging mental health conditions.
Recognizing the complexities and challenges of navigating the application process, ATMA CENA, alongside healthcare professionals, facilitates the entire application process on behalf of the clients. This includes assistance from application submission to the delivery of Psilocybin Assisted Therapy, simplifying the journey toward accessing this potentially life-changing treatment. Our dedicated effort aims to bring relief and hope to those seeking alternative solutions in their healthcare journey, making innovative therapeutic options more accessible to those in need.
A $300 non-refundable deposit is required for all ATMA CENA treatment programs, which will be applied toward your treatment.
Our MDMA Assisted Therapy program
Health Canada Application Fee
To gain access to MDMA, special approval from Health Canada is required. We can facilitate this application for you. Deposit breakdown: $300 non-refundable deposit & $200 application fee.
This application fee is non-refundable.
$500 CAD
First & Second Doses of MDMA
Each dose of MDMA is paired with therapy. This process includes a psychiatric assessment & clinical assessment.
A medicine session takes 6 hours and requires at least 8 hours of additional clinical and therapy support.
$6,390 CAD
Third Dose of MDMA
A third dose may be administered as needed, paired with therapy and assessments.
$2,395 CAD
Psilocybin-Assisted Therapy Program
Personalized treatment plans for your unique healing journey.
Application Fee
Customized Treatment Program
Access to Psilocybin-assisted therapy requires special approval from Health Canada. If you are interested in exploring this option, we can facilitate the application process.
Psilocybin-assisted therapy is a highly personalized process. Each treatment plan is tailored to the individual, ensuring the best possible care and outcomes.
💰 The application fee is $850.00
(This includes a $300.00 non-refundable deposit plus $550.00 for the application fee)
- A consultation is required to determine your treatment plan and pricing.
- Our team will work with you to create a customized program based on your needs.
Application Fee
Access to MDMA-assisted therapy requires special approval from Health Canada. If you are interested in exploring this option, we can facilitate the application process.
💰 The application fee is $850.00
(This includes a $300.00 non-refundable deposit plus $550.00 for the application fee)
Customized Treatment Program
MDMA-assisted therapy is a highly personalized process. Each treatment plan is tailored to the individual, ensuring the best possible care and outcomes.
- A consultation is required to determine your treatment plan and pricing.
- Our team will work with you to create a customized program based on your needs.
For more details on your personalized treatment options, book a consultation with our team today!
Schedule a free Information
Call to get started
Learn more about Psilocybin
- How Psilocybin Reduces Symptoms of Depression | Psychology Today
- How Magic Mushrooms Can Fix Depression | Psychology Today
- Psilocybin for Depression: What You Need to Know | verywellmind.com
- Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows | Johns Hopkins Medicine
Disclaimer
Psilocybin has not received approval from Health Canada or the Food and Drug Administration for treating any mental health conditions. This page offers information strictly for educational purposes and does not comprehensively cover the current research on psychedelic treatments, including their effectiveness, contraindications, risks, side effects, or other relevant details. For further information, please refer to our Disclaimers in our Terms of Use.
